| Literature DB >> 26819509 |
Carlo Palazzi1, Emilio D'Amico1, Salvatore D'Angelo1, Michele Gilio1, Ignazio Olivieri1.
Abstract
Hepatitis C virus (HCV) is a hepato- and lymphotropic agent that is able to induce several autoimmune rheumatic disorders: vasculitis, sicca syndrome, arthralgias/arthritis and fibromyalgia. The severity of clinical manifestations is variable and sometimes life-threatening. HCV infection can mimic many primitive rheumatic diseases, therefore, it is mandatory to distinguish HCV-related manifestations from primitive ones because the prognosis and therapeutic strategies can be fairly dissimilar. The new direct-acting antivirals drugs can help to avoid the well-known risks of worsening or new onset of autoimmune diseases during the traditional interferon-based therapies.Entities:
Keywords: Arthritis; Cryoglobulinemia; Diagnosis; Hepatitis C; Hepatitis C virus; Rheumatic; Sicca syndrome; Vasculitis
Mesh:
Substances:
Year: 2016 PMID: 26819509 PMCID: PMC4721975 DOI: 10.3748/wjg.v22.i4.1405
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742